Study Details
Full Title
A Phase IIIb, open label, pragmatic study evaluating initiation strategies for survodutide, including de novo use and switching from semaglutide or tirzepatide, in participants with overweight/obesity without diabetes mellitus-SYNCHRONIZE-START
Principal Investigator
Mustafa
Bashir
Protocol Number
PRO00120673
Phase
N/A
Enrollment Status
Open to Enrollment